Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors

NCT01445509 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

NIH

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: Bevacizumab
DRUG: Dasatinib

Sponsor

National Cancer Institute (NCI)